|
1
|
André T, Boni C, Mounedji-Boudiaf L,
Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan
P, Bridgewater J, et al: Oxaliplatin, fluorouracil, and leucovorin
as adjuvant treatment for colon cancer. N Engl J Med.
350:2343–2351. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu R, Zhou B, Fung PC and Li X: Recent
advances in the treatment of colon cancer. Histol Histopathol.
21:867–872. 2006.PubMed/NCBI
|
|
3
|
Morales M, Ávila J, González-Fernández R,
Boronat L, Soriano ML and Martín-Vasallo P: Differential
transcriptome profile of peripheral white cells to identify
biomarkers involved in oxaliplatin induced neuropathy. J Pers Med.
4:282–296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rotoli D, Morales M, Del Carmen Maeso M,
Del Pino García M, Morales A, Avila J and Martín-Vasallo P:
Expression and localization of the immunophilin FKBP51 in
colorectal carcinomas and primary metastases, and alterations
following oxaliplatin-based chemotherapy. Oncol Lett. 12:1315–1322.
2016.PubMed/NCBI
|
|
5
|
Johnson M, Sharma M and Henderson BR:
IQGAP1 regulation and roles in cancer. Cell Signal. 21:1471–1478.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
White CD, Brown MD and Sacks DB: IQGAPs in
cancer: A family of scaffold proteins underlying tumorigenesis.
FEBS Lett. 583:1817–1824. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Erickson JW, Cerione RA and Hart MJ:
Identification of an actin cytoskeletal complex that includes IQGAP
and the Cdc42 GTPase. J Biol Chem. 272:24443–24447. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roy M, Li Z and Sacks DB: IQGAP1 is a
scaffold for mitogen-activated protein kinase signaling. Mol Cell
Biol. 25:7940–7952. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McDonald KL, O'Sullivan MG, Parkinson JF,
Shaw JM, Payne CA, Brewer JM, Young L, Reader DJ, Wheeler HT, Cook
RJ, et al: IQGAP1 and IGFBP2: Valuable biomarkers for determining
prognosis in glioma patients. J Neuropathol Exp Neurol. 66:405–417.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nabeshima K, Shimao Y, Inoue T and Koono
M: Immunohistochemical analysis of IQGAP1 expression in human
colorectal carcinomas: Its overexpression in carcinomas and
association with invasion fronts. Cancer Lett. 176:101–109. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Holck S, Nielsen HJ, Hammer E, Christensen
IJ and Larsson LI: IQGAP1 in rectal adenocarcinomas: Localization
and protein expression before and after radiochemotherapy. Cancer
Lett. 356:556–560. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takemoto H, Doki Y, Shiozaki H, Imamura H,
Utsunomiya T, Miyata H, Yano M, Inoue M, Fujiwara Y and Monden M:
Localization of IQGAP1 is inversely correlated with intercellular
adhesion mediated by e-cadherin in gastric cancers. Int J Cancer.
91:783–788. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fukata M, Watanabe T, Noritake J, Nakagawa
M, Yamaga M, Kuroda S, Matsuura Y, Iwamatsu A, Perez F and Kaibuchi
K: Rac1 and Cdc42 capture microtubules through IQGAP1 and CLIP-170.
Cell. 109:873–885. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Watanabe T, Wang S, Noritake J, Sato K,
Fukata M, Takefuji M, Nakagawa M, Izumi N, Akiyama T and Kaibuchi
K: Interaction with IQGAP1 links APC to Rac1, Cdc42, and actin
filaments during cell polarization and migration. Dev Cell.
7:871–883. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Johnson MA and Henderson BR: The
scaffolding protein IQGAP1 co-localizes with actin at the
cytoplasmic face of the nuclear envelope: Implications for
cytoskeletal regulation. Bioarchitecture. 2:138–142. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Noritake J, Watanabe T, Sato K, Wang S and
Kaibuchi K: IQGAP1: A key regulator of adhesion and migration. J
Cell Sci. 118:2085–2092. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakhaei-Nejad M, Zhang QX and Murray AG:
Endothelial IQGAP1 regulates efficient lymphocyte transendothelial
migration. Eur J Immunol. 40:204–213. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamaoka-Tojo M, Tojo T, Kim HW, Hilenski
L, Patrushev NA, Zhang L, Fukai T and Ushio-Fukai M: IQGAP1
mediates VE-cadherin-based cell-cell contacts and VEGF signaling at
adherence junctions linked to angiogenesis. Arterioscler Thromb
Vasc Biol. 26:1991–1997. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guzińska-Ustymowicz K, Pryczynicz A,
Kemona A and Czyzewska J: Correlation between proliferation
markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in
colorectal cancer. Anticancer Res. 29:3049–3052. 2009.PubMed/NCBI
|
|
20
|
Bleau AM, Agliano A, Larzabal L, de
Aberasturi AL and Calvo A: Metastatic dormancy: A complex network
between cancer stem cells and their microenvironment. Histol
Histopathol. 29:1499–1510. 2014.PubMed/NCBI
|
|
21
|
Moldovan GL, Pfander B and Jentsch S:
PCNA, the maestro of the replication fork. Cell. 129:665–679. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Connolly KM and Bogdanffy MS: Evaluation
of proliferating cell nuclear antigen (PCNA) as an endogenous
marker of cell proliferation in rat liver: A dual-stain comparison
with 5-bromo-2′-deoxyuridine. J Histochem Cytochem. 41:1–6. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Johnson M, Sharma M, Brocardo MG and
Henderson BR: IQGAP1 translocates to the nucleus in early S-phase
and contributes to cell cycle progression after DNA replication
arrest. Int J Biochem Cell Biol. 43:65–73. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bielak-Zmijewska A, Kolano A, Szczepanska
K, Maleszewski M and Borsuk E: Cdc42 protein acts upstream of
IQGAP1 and regulates cytokinesis in mouse oocytes and embryos. Dev
Biol. 322:21–32. 2008. View Article : Google Scholar : PubMed/NCBI
|
